APR January/February 2022 - 68

» FORMULATION AND DEVELOPMENT
»
Figure 7. " Transfer Ready " Artifacts
Conclusions and Next Steps
The original IQ working group envisioned a broad strategy for
advancing laboratory informatics. The focus of this paper, and the
ETC project, was centered on the evaluation of laboratory wearables.
However, through this experience the member companies were able
to expand to other areas of interest. Our discussions highlighted a
synergistic approach using the expertise of two different vendors
regarding wearables and platform technology to work in parallel.
This created a dynamic environment where the consortia companies
formulated complimentary use cases for their sites that evaluated
the unique challenges for Integrated Laboratory Notebook,
Dynamic Procedural Support and Technical Transfer and Third-Party
Organizations. The ensuing collaborations extended the original
use case goals with an overarching proof of concept leading to the
following notable findings and accomplishments:
* The partners were able to create an immersive lab experience,
using wearables, with a familiar workflow and interface that
leveraged MS365. The premise of using the MS365 platform
as a laboratory notebook is game changing to the industry.
The ubiquitous nature of these tools makes the sharing of
information much easier. Moreover, there is no need for
additional infrastructure compared to a specialized ELN. The
MS365 platform incorporates current state audio and visual
technology that brings the tools scientist use at home to their
laboratories.
68 |
| January/February 2022
* Use of annotated SOPs created dynamic procedure support
with a digital stepwise workflow using the wearables to collect
scientific information in a findable, accessible, interoperable,
and reusable way. This led to successful evaluation of remote
guidance, more independent use and transferability ease of
procedures.
* The inherent familiarity of Varya's Iota platform coupled with
Apprentice wearable technology enabled research, experiments
and results to be captured easily. As the same MS365 capabilities
are commonplace it creates real-time collaboration experience.
This raises the possibility of more " bench work " collaboration
and the possibilities of bringing unique skillsets, knowledge and
experience closer together for innovation and problem solving.
An ETC project team comprised of members of multiple pharmaceutical
companies has a clear advantage where members come from distinct
aspects of the development organization and represent diverse
organizational missions and institutional structures. Eli Lilly scientists
were looking to orchestrate data for downstream uses. Biogen focused
on internal lab efficiency through procedural execution. BMS sought
to bring the two technologies together for a complete workflow
experience. This diversity of the use cases enriched the pilot, and
likely would have been insurmountable for a single company acting
alone. Overall, each use case was a successful application of wearable
technology that incorporated future-looking platform technology
but also demonstrated opportunities for further development.
Crucially this enables scientist to focus on experiments, collaboration,

APR January/February 2022

Table of Contents for the Digital Edition of APR January/February 2022

APR January/February 2022 - Cover1
APR January/February 2022 - Cover2
APR January/February 2022 - 1
APR January/February 2022 - 2
APR January/February 2022 - 3
APR January/February 2022 - 4
APR January/February 2022 - 5
APR January/February 2022 - 6
APR January/February 2022 - 7
APR January/February 2022 - 8
APR January/February 2022 - 9
APR January/February 2022 - 10
APR January/February 2022 - 11
APR January/February 2022 - 12
APR January/February 2022 - 13
APR January/February 2022 - 14
APR January/February 2022 - 15
APR January/February 2022 - 16
APR January/February 2022 - 17
APR January/February 2022 - 18
APR January/February 2022 - 19
APR January/February 2022 - 20
APR January/February 2022 - 21
APR January/February 2022 - 22
APR January/February 2022 - 23
APR January/February 2022 - 24
APR January/February 2022 - 25
APR January/February 2022 - 26
APR January/February 2022 - 27
APR January/February 2022 - 28
APR January/February 2022 - 29
APR January/February 2022 - 30
APR January/February 2022 - 31
APR January/February 2022 - 32
APR January/February 2022 - 33
APR January/February 2022 - 34
APR January/February 2022 - 35
APR January/February 2022 - 36
APR January/February 2022 - 37
APR January/February 2022 - 38
APR January/February 2022 - 39
APR January/February 2022 - 40
APR January/February 2022 - 41
APR January/February 2022 - 42
APR January/February 2022 - 43
APR January/February 2022 - 44
APR January/February 2022 - 45
APR January/February 2022 - 46
APR January/February 2022 - 47
APR January/February 2022 - 48
APR January/February 2022 - 49
APR January/February 2022 - 50
APR January/February 2022 - 51
APR January/February 2022 - 52
APR January/February 2022 - 53
APR January/February 2022 - 54
APR January/February 2022 - 55
APR January/February 2022 - 56
APR January/February 2022 - 57
APR January/February 2022 - 58
APR January/February 2022 - 59
APR January/February 2022 - 60
APR January/February 2022 - 61
APR January/February 2022 - 62
APR January/February 2022 - 63
APR January/February 2022 - 64
APR January/February 2022 - 65
APR January/February 2022 - 66
APR January/February 2022 - 67
APR January/February 2022 - 68
APR January/February 2022 - 69
APR January/February 2022 - 70
APR January/February 2022 - 71
APR January/February 2022 - 72
APR January/February 2022 - 73
APR January/February 2022 - 74
APR January/February 2022 - 75
APR January/February 2022 - 76
APR January/February 2022 - 77
APR January/February 2022 - 78
APR January/February 2022 - 79
APR January/February 2022 - 80
APR January/February 2022 - 81
APR January/February 2022 - 82
APR January/February 2022 - 83
APR January/February 2022 - 84
APR January/February 2022 - Cover3
APR January/February 2022 - Cover4
https://www.nxtbookmedia.com